In a patient with elevated red blood cell count, hemoglobin, hematocrit, hypercalcemia with high ionized calcium, and an elevated intact parathyroid hormone level while all other labs are normal, what is the most likely diagnosis and what further evaluation and management are recommended?

Primary Hyperparathyroidism (PHPT)

This patient has primary hyperparathyroidism (PHPT), confirmed by the combination of hypercalcemia (total calcium 11.1 mg/dL, ionized calcium 5.8 mg/dL) with an inappropriately elevated PTH (66 pg/mL). The elevated RBC parameters (RBC 5.71, hemoglobin 16.3, hematocrit 50.4) are likely secondary to hemoconcentration or unrelated, and should not distract from the primary diagnosis.

Diagnostic Confirmation

The biochemical profile is classic for PHPT 1:

• Hypercalcemia with elevated ionized calcium (5.8 mg/dL, above normal)
• Elevated PTH (66 pg/mL) that is inappropriate for the calcium level
• Normal vitamin D (35.3 ng/mL), ruling out vitamin D deficiency as a cause of secondary hyperparathyroidism

This represents the typical biochemical presentation combining hypercalcemia with elevated PTH 1. The diagnosis is straightforward and does not require additional confirmatory testing like calcium loading tests, which are reserved for atypical presentations 1.

Mandatory Target-Organ Assessment

You must now systematically evaluate for end-organ damage, as this is frequently asymptomatic but determines surgical candidacy 1:

Renal Evaluation (Grade A++)

• 24-hour urine calcium and fasting calcium/creatinine ratio
• Low-dose non-contrast CT scan of kidneys (more sensitive than ultrasound for detecting asymptomatic kidney stones or nephrocalcinosis) 1
• Clinical screening for kidney stone symptoms
• eGFR is already documented (81 mL/min/1.73m²)

Bone Evaluation (Grade A++)

• DEXA scan measuring spine, femur, AND distal one-third radius 1
• Spine X-rays or vertebral fracture assessment to detect asymptomatic vertebral fractures 1

Additional Considerations

• Rule out familial hypocalciuric hypercalcemia (FHH) by calculating fractional excretion of calcium (FeCa) from the 24-hour urine collection 1. FeCa >2% supports PHPT; ≤2% suggests FHH
• Screen for genetic causes if patient is young, has family history, or has multiglandular disease 1

Management Algorithm

Surgical Indications

Parathyroidectomy is the definitive treatment and should be offered if ANY of the following criteria are met 1, 2, 3:

1. Symptomatic disease (kidney stones, fractures, bone pain)
2. Age <50 years
3. Serum calcium >1 mg/dL above upper limit of normal (this patient has calcium 11.1 mg/dL; if upper limit is ~10.5 mg/dL, this criterion may be met)
4. eGFR <60 mL/min
5. Presence of kidney stones or nephrocalcinosis
6. T-score ≤-2.5 at any site OR vertebral fracture
7. Hypercalciuria (>400 mg/24 hours)

Pre-Surgical Imaging (if surgery indicated)

First-line imaging 1:

• Parathyroid ultrasound PLUS
• Dual-isotope scintigraphy (123I/99mTc-Sestamibi) OR 18F-Choline PET-CT

If these are non-localizing, refer to expert center for 4D-CT or MRI 1.

Conservative Management (if surgery declined or not indicated)

For patients >50 years with calcium <1 mg/dL above normal and no end-organ damage 1, 2:

• Monitor serum calcium every 6-12 months
• Repeat DEXA every 1-2 years
• Maintain adequate hydration
• Avoid thiazide diuretics and excessive calcium/vitamin D supplementation
• Do NOT restrict dietary calcium - this paradoxically increases PTH 4

Critical Pitfalls to Avoid

1. Do not assume the elevated RBC parameters are related to PHPT - these are likely incidental or due to dehydration. PHPT does not cause polycythemia.

2. Do not delay target-organ assessment - asymptomatic kidney stones and bone disease are common and change management 1.

3. Do not restrict dietary calcium in PHPT patients - low calcium intake worsens PTH elevation 4.

4. Do not confuse this with secondary hyperparathyroidism - the patient has normal vitamin D and normal renal function, and the PTH is elevated WITH hypercalcemia (not compensatory) 1.

5. Always measure ionized calcium when total calcium is borderline or when monoclonal proteins are present (not applicable here, but important principle) 5.

Prognosis

Asymptomatic PHPT has excellent prognosis with either surgical or medical management 2. Surgery is curative in >95% of cases when performed by experienced endocrine surgeons 1, 3. Without treatment, approximately 25-30% of asymptomatic patients will develop indications for surgery over 10-15 years of follow-up.